Advantages of early replacement therapy for mucopolysaccharidosis type VI: echocardiographic follow-up of siblings.
Cardiol Young
; 24(2): 229-35, 2014 Apr.
Article
in En
| MEDLINE
| ID: mdl-23458163
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Aortic Valve Insufficiency
/
Recombinant Proteins
/
Mucopolysaccharidosis VI
/
N-Acetylgalactosamine-4-Sulfatase
/
Siblings
/
Enzyme Replacement Therapy
/
Early Medical Intervention
/
Mitral Valve Insufficiency
/
Cardiomyopathies
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Child
/
Female
/
Humans
/
Infant
Language:
En
Journal:
Cardiol Young
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
PEDIATRIA
Year:
2014
Document type:
Article
Affiliation country:
Brasil
Country of publication:
Reino Unido